Sharma Ramesh Kumar
Department of Plastic Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Plast Reconstr Surg Glob Open. 2020 Mar 27;8(3):e2696. doi: 10.1097/GOX.0000000000002696. eCollection 2020 Mar.
Craniofacial surgery as a subspecialty has finally taken off in India. Young plastic surgeons in the early 1990s became fascinated by its enormous scope. The author was also among the lucky ones to be trained in this field with Dr. Ian Jackson at the Craniofacial Center at Southfield, Michigan, from 1993-1994. This facility for craniofacial surgery was established in the North Indian tertiary care hospital at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, in 1995.
We have reviewed the outcomes of management of craniosynostosis patients and evaluated changes in these outcomes as the experience was gained. The study is a retrospective chart review of the 169 patients operated on for various craniosyntoses in the hospital, for the last 25 years from January 1995 to July 2019.
The whole spectrum of craniosynostoses patients have been operated on and followed up for up to 20 years. All the patients underwent open surgery involving fronto-orbital advancement and remodelling of the deformed calvarium. It was noted that all the syndromic patients required more than one operation, whereas the non-syndromic patients had a stable result after a single surgery. Craniofacial surgery has now truly arrived in India. Our experience with management of craniosynostosis at PGIMER, Chandigarh, has shown an acceptable morbidity and mortality which is at par with the global standards.
颅面外科作为一个亚专业在印度终于兴起。20世纪90年代初,年轻的整形外科医生被其广阔的发展前景所吸引。作者也是幸运儿之一,1993年至1994年期间在密歇根州南菲尔德颅面中心跟随伊恩·杰克逊医生接受该领域的培训。1995年,印度北部昌迪加尔医学教育与研究研究生院(PGIMER)的三级护理医院设立了颅面外科设施。
我们回顾了颅缝早闭患者的治疗结果,并随着经验的积累评估这些结果的变化。该研究是对1995年1月至2019年7月过去25年在该医院接受各种颅缝早闭手术的169例患者的回顾性病历审查。
对所有类型的颅缝早闭患者进行了手术,并随访了长达二十年。所有患者均接受了涉及额眶前移和重塑变形颅骨的开放性手术。结果发现,所有综合征患者都需要进行不止一次手术,而非综合征患者单次手术后效果稳定。颅面外科如今已真正在印度落地生根。我们在昌迪加尔PGIMER进行颅缝早闭治疗的经验表明,其发病率和死亡率在可接受范围内,与全球标准相当。